Combating antibiotic Resistant Bacteria Biopharmaceutical Accelerator or Carb-X for short is bringing together the United States and British health officials, academia and industry to accelerate the development of new antibiotics. Read article here…..
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.